当前位置: X-MOL 学术Leukemia › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time
Leukemia ( IF 12.8 ) Pub Date : 2017-11-16 , DOI: 10.1038/leu.2017.331
S K Kumar , A Dispenzieri , R Fraser , F Mingwei , G Akpek , R Cornell , M Kharfan-Dabaja , C Freytes , S Hashmi , G Hildebrandt , L Holmberg , R Kyle , H Lazarus , C Lee , J Mikhael , T Nishihori , J Tay , S Usmani , D Vesole , R Vij , B Wirk , A Krishnan , C Gasparetto , T Mark , Y Nieto , P Hari , A D'Souza

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time, Published online: 16 November 2017; doi:10.1038/leu.2017.331



中文翻译:

自体造血细胞移植后的早期复发仍是多发性骨髓瘤的不良预后因素,但结局随着时间的推移有所改善

自体造血细胞移植后的早期复发仍是多发性骨髓瘤的不良预后因素,但结局随着时间的推移有所改善

自体造血细胞移植后的早期复发仍然是多发性骨髓瘤的不良预后因素,但随着时间的推移其疗效有所改善,在线发表:2017年11月16日;doi:10.1038 / leu.2017.331

更新日期:2017-11-16
down
wechat
bug